
Recovery
BPC-157 (10mg)
R550

Recovery
A regenerative peptide supporting systemic healing, mobility, and soft-tissue recovery.
R1 150
Recommended by the Stack Finder in
Thymosin beta-4 (17-23) fragment
A systemic repair peptide derived from thymosin beta-4, studied for wound healing and tissue regeneration.
Overview of how thymosin beta-4 sequesters actin and promotes repair in heart, skin, eye and nervous tissue models.
Goldstein AL et al. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11:421-429. doi:10.1016/j.molmed.2005.07.004
Intravenous full-length thymosin beta-4 was safe in a randomised single and multiple dose study of healthy volunteers.
Ruff D et al. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. Ann N Y Acad Sci. 2010;1194:223-229. doi:10.1111/j.1749-6632.2010.05474.x
Topical thymosin beta-4 was evaluated for venous ulcer healing in a European randomised study.
Guarnera G et al. The effect of thymosin treatment of venous ulcers. Ann N Y Acad Sci. 2010;1194:207-212. doi:10.1111/j.1749-6632.2010.05490.x
A regenerative peptide supporting systemic healing, mobility, and soft-tissue recovery.
TB-500 10mg is a synthetic peptide derived from the active region of thymosin beta-4, a naturally occurring protein involved in tissue repair and cellular migration. It is widely explored for its role in supporting whole-body recovery, mobility, and soft-tissue healing.
Unlike localised repair peptides, TB-500 is known for its systemic action, making it particularly relevant for individuals seeking full-body recovery support rather than site-specific intervention.
TB-500 is a peptide fragment of thymosin beta-4, a protein naturally present in many tissues throughout the body. It plays a role in cellular movement, repair signalling, and tissue regeneration.
Its ability to circulate systemically has made TB-500 a popular option for those focused on broad recovery, structural resilience, and long-term mobility.
TB-500 is commonly explored for its role in supporting:
• Soft-tissue repair and regeneration
• Muscle recovery and mobility
• Tendon and ligament resilience
• Reduced stiffness following injury or intense training
• Whole-body recovery rather than localised repair
By supporting cellular repair processes across multiple tissues, TB-500 aligns with a longevity-focused approach to movement, recovery, and physical resilience.
• Supports systemic tissue repair
• Assists muscle, tendon, and ligament recovery
• Promotes mobility and flexibility
• Supports recovery from injury or physical stress
• Longevity-aligned approach to whole-body recovery
TB-500 may be well suited for individuals who:
• Are recovering from injury or chronic physical strain
• Experience stiffness or reduced mobility
• Train intensely and prioritise recovery
• Want full-body repair support rather than site-specific solutions
• Are focused on long-term movement and structural health
This peptide is commonly chosen by those seeking comprehensive recovery and sustained physical performance.
• Peptide: TB-500
• Amount: 10mg per vial
• Format: Lyophilised (freeze-dried) powder
• Category: Systemic Recovery | Tissue Repair | Mobility & Longevity
• Storage: Refrigerate after reconstitution
This peptide requires reconstitution prior to use. Bacteriostatic water is included with your order for convenience.
• Reconstitution Syringe
• Insulin Syringes
• Alcohol Swabs
These essentials can be added below for convenience.
Q: What makes TB-500 different from BPC-157?
A: TB-500 is commonly discussed as having a more systemic effect, supporting recovery processes throughout the body.
Q: What type of recovery is TB-500 associated with?
A: It is often explored for full-body recovery, mobility, and overall tissue support.
Q: Can TB-500 be used as part of a stack?
A: It is frequently combined with other peptides to support a more comprehensive recovery strategy.
This product is intended for research and educational purposes only.
Always consult a qualified healthcare professional before beginning any new peptide protocol.